Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

PERK Regulates Glioblastoma Sensitivity to ER Stress While Promoting Radiation Resistance.

Dadey DY, Kapoor V, Khudanyan A, Thotala D, Hallahan DE.

Mol Cancer Res. 2018 Jul 10. pii: molcanres.0224.2018. doi: 10.1158/1541-7786.MCR-18-0224. [Epub ahead of print]

PMID:
29991528
2.

A convenient, reliable, and fast acoustic pressure field measurement method for magnetic resonance-guided high-intensity focused ultrasound systems with phased array transducers.

Kothapalli SVVN, Partanen A, Zhu L, Altman MB, Gach HM, Hallahan DE, Chen H.

J Ther Ultrasound. 2018 Jul 2;6:5. doi: 10.1186/s40349-018-0113-7. eCollection 2018.

3.

Transient PP2A inhibition alleviates normal tissue stem cell susceptibility to cell death during radiotherapy.

Fabbrizi MR, Meyer B, Misri S, Raj S, Zobel CL, Hallahan DE, Sharma GG.

Cell Death Dis. 2018 May 1;9(5):492. doi: 10.1038/s41419-018-0559-0.

4.

Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.

Acharya S, Robinson CG, Michalski JM, Mullen D, DeWees TA, Campian JL, Chundury A, Bottani B, Hallahan DE, Bradley JD, Huang J.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):334-343. doi: 10.1016/j.ijrobp.2018.01.099. Epub 2018 Feb 9.

PMID:
29534896
5.

Evaluation and selection of anatomic sites for magnetic resonance imaging-guided mild hyperthermia therapy: a healthy volunteer study.

V V N Kothapalli S, Altman MB, Zhu L, Partanen A, Cheng G, Gach HM, Straube W, Zoberi I, Hallahan DE, Chen H.

Int J Hyperthermia. 2018 Jan 4:1-9. doi: 10.1080/02656736.2017.1418536. [Epub ahead of print]

PMID:
29301453
6.

Acoustic field characterization of a clinical magnetic resonance-guided high-intensity focused ultrasound system inside the magnet bore.

Kothapalli SVVN, Altman MB, Partanen A, Wan L, Gach HM, Straube W, Hallahan DE, Chen H.

Med Phys. 2017 Sep;44(9):4890-4899. doi: 10.1002/mp.12412. Epub 2017 Jul 25.

PMID:
28626862
7.

Histone H3 Lysine 9 Acetylation Obstructs ATM Activation and Promotes Ionizing Radiation Sensitivity in Normal Stem Cells.

Meyer B, Fabbrizi MR, Raj S, Zobel CL, Hallahan DE, Sharma GG.

Stem Cell Reports. 2016 Dec 13;7(6):1013-1022. doi: 10.1016/j.stemcr.2016.11.004.

8.

An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma.

Gujar AD, Le S, Mao DD, Dadey DY, Turski A, Sasaki Y, Aum D, Luo J, Dahiya S, Yuan L, Rich KM, Milbrandt J, Hallahan DE, Yano H, Tran DD, Kim AH.

Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):E8247-E8256. doi: 10.1073/pnas.1610921114. Epub 2016 Dec 7.

9.

Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non-Small Cell Lung Cancer Cell Lines and Tumor Models.

Dadey DYA, Kapoor V, Hoye K, Khudanyan A, Collins A, Thotala D, Hallahan DE.

Clin Cancer Res. 2017 May 15;23(10):2556-2564. doi: 10.1158/1078-0432.CCR-16-1935. Epub 2016 Nov 4.

10.

Retargeted adenoviruses for radiation-guided gene delivery.

Kaliberov SA, Kaliberova LN, Yan H, Kapoor V, Hallahan DE.

Cancer Gene Ther. 2016 Sep;23(9):303-14. doi: 10.1038/cgt.2016.32. Epub 2016 Aug 5.

11.

Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers.

Kapoor V, Dadey DY, Nguyen K, Wildman SA, Hoye K, Khudanyan A, Bandara N, Rogers BE, Thotala D, Hallahan DE.

J Nucl Med. 2016 Dec;57(12):1991-1997. Epub 2016 Jul 21.

12.

Unique epigenetic influence of H2AX phosphorylation and H3K56 acetylation on normal stem cell radioresponses.

Jacobs KM, Misri S, Meyer B, Raj S, Zobel CL, Sleckman BP, Hallahan DE, Sharma GG.

Mol Biol Cell. 2016 Apr 15;27(8):1332-45. doi: 10.1091/mbc.E16-01-0017. Epub 2016 Mar 3.

13.

The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma.

Dadey DY, Kapoor V, Khudanyan A, Urano F, Kim AH, Thotala D, Hallahan DE.

Oncotarget. 2016 Jan 12;7(2):2080-92. doi: 10.18632/oncotarget.6712.

14.

A Gamma-Knife-Enabled Mouse Model of Cerebral Single-Hemisphere Delayed Radiation Necrosis.

Jiang X, Yuan L, Engelbach JA, Cates J, Perez-Torres CJ, Gao F, Thotala D, Drzymala RE, Schmidt RE, Rich KM, Hallahan DE, Ackerman JJ, Garbow JR.

PLoS One. 2015 Oct 6;10(10):e0139596. doi: 10.1371/journal.pone.0139596. eCollection 2015.

15.

Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.

Thotala D, Karvas RM, Engelbach JA, Garbow JR, Hallahan AN, DeWees TA, Laszlo A, Hallahan DE.

Oncotarget. 2015 Oct 27;6(33):35004-22. doi: 10.18632/oncotarget.5253.

16.

Specificity of vascular endothelial growth factor treatment for radiation necrosis.

Perez-Torres CJ, Yuan L, Schmidt RE, Rich KM, Drzymala RE, Hallahan DE, Ackerman JJ, Garbow JR.

Radiother Oncol. 2015 Nov;117(2):382-5. doi: 10.1016/j.radonc.2015.09.004. Epub 2015 Sep 12.

17.

Silencing Egr1 Attenuates Radiation-Induced Apoptosis in Normal Tissues while Killing Cancer Cells and Delaying Tumor Growth.

Zhao DY, Jacobs KM, Hallahan DE, Thotala D.

Mol Cancer Ther. 2015 Oct;14(10):2343-52. doi: 10.1158/1535-7163.MCT-14-1051. Epub 2015 Jul 23.

18.

Stem Cell Transfusion Restores Immune Function in Radiation-Induced Lymphopenic C57BL/6 Mice.

Kapoor V, Khudanyan A, de la Puente P, Campian J, Hallahan DE, Azab AK, Thotala D.

Cancer Res. 2015 Sep 1;75(17):3442-5. doi: 10.1158/0008-5472.CAN-15-1412. Epub 2015 Jun 30.

19.

A GSK-3β inhibitor protects against radiation necrosis in mouse brain.

Jiang X, Perez-Torres CJ, Thotala D, Engelbach JA, Yuan L, Cates J, Gao F, Drzymala RE, Rich KM, Schmidt RE, Ackerman JJ, Hallahan DE, Garbow JR.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):714-21. doi: 10.1016/j.ijrobp.2014.04.018.

20.

Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

Jiang X, Engelbach JA, Yuan L, Cates J, Gao F, Drzymala RE, Hallahan DE, Rich KM, Schmidt RE, Ackerman JJ, Garbow JR.

Clin Cancer Res. 2014 May 15;20(10):2695-702. doi: 10.1158/1078-0432.CCR-13-1941. Epub 2014 Mar 19.

21.

Thoughts on the future of research, teaching, and testing in the biological sciences of radiation oncology.

Hallahan DE, Freeman ML.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):1-2. doi: 10.1016/j.ijrobp.2013.09.048. No abstract available.

PMID:
24331646
22.

Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines.

Bhave SR, Dadey DY, Karvas RM, Ferraro DJ, Kotipatruni RP, Jaboin JJ, Hallahan AN, Dewees TA, Linkous AG, Hallahan DE, Thotala D.

Front Oncol. 2013 Sep 17;3:236. doi: 10.3389/fonc.2013.00236. eCollection 2013.

23.

Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models.

Thotala D, Craft JM, Ferraro DJ, Kotipatruni RP, Bhave SR, Jaboin JJ, Hallahan DE.

PLoS One. 2013 Jul 19;8(7):e69688. doi: 10.1371/journal.pone.0069688. Print 2013.

24.

Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.

Laszlo A, Thotala D, Hallahan DE.

Cancer J. 2013 May-Jun;19(3):238-46. doi: 10.1097/PPO.0b013e31829a68eb. Review.

25.

In regard to Shah.

Hallahan DE, Perkins SM.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):597. doi: 10.1016/j.ijrobp.2013.04.004. Epub 2013 May 9. No abstract available.

PMID:
23664328
26.

High-throughput identification of putative receptors for cancer-binding peptides using biopanning and microarray analysis.

Ferraro DJ, Bhave SR, Kotipatruni RP, Hunn JC, Wildman SA, Hong C, Dadey DY, Muhoro LK, Jaboin JJ, Thotala D, Hallahan DE.

Integr Biol (Camb). 2013 Feb;5(2):342-50. doi: 10.1039/c2ib20187a.

27.

NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.

Kotipatruni RP, Ferraro DJ, Ren X, Vanderwaal RP, Thotala DK, Hallahan DE, Jaboin JJ.

Integr Biol (Camb). 2012 Oct;4(10):1185-97.

PMID:
22869042
28.

GSK-3β: A Bifunctional Role in Cell Death Pathways.

Jacobs KM, Bhave SR, Ferraro DJ, Jaboin JJ, Hallahan DE, Thotala D.

Int J Cell Biol. 2012;2012:930710. doi: 10.1155/2012/930710. Epub 2012 May 21.

29.

Kinomic profiling approach identifies Trk as a novel radiation modulator.

Jarboe JS, Jaboin JJ, Anderson JC, Nowsheen S, Stanley JA, Naji F, Ruijtenbeek R, Tu T, Hallahan DE, Yang ES, Bonner JA, Willey CD.

Radiother Oncol. 2012 Jun;103(3):380-7. doi: 10.1016/j.radonc.2012.03.014. Epub 2012 May 5.

30.

Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.

Schleicher SM, Thotala DK, Linkous AG, Hu R, Leahy KM, Yazlovitskaya EM, Hallahan DE.

PLoS One. 2011;6(7):e22182. doi: 10.1371/journal.pone.0022182. Epub 2011 Jul 20.

31.

Glycogen synthase kinase 3β inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway.

Thotala DK, Hallahan DE, Yazlovitskaya EM.

Cell Death Differ. 2012 Mar;19(3):387-96. doi: 10.1038/cdd.2011.94. Epub 2011 Jul 8.

32.

Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer.

Schulte RR, Linkous AG, Hallahan DE, Yazlovitskaya EM.

Cancer Lett. 2011 May 28;304(2):137-43. doi: 10.1016/j.canlet.2011.02.015.

33.

Multifunctional FePt nanoparticles for radiation-guided targeting and imaging of cancer.

Hariri G, Wellons MS, Morris WH 3rd, Lukehart CM, Hallahan DE.

Ann Biomed Eng. 2011 Mar;39(3):946-52. doi: 10.1007/s10439-010-0219-8. Epub 2010 Dec 4.

34.

Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors.

Lowery A, Onishko H, Hallahan DE, Han Z.

J Control Release. 2011 Feb 28;150(1):117-24. doi: 10.1016/j.jconrel.2010.11.006. Epub 2010 Nov 12.

35.

Radiation-guided drug delivery to mouse models of lung cancer.

Hariri G, Yan H, Wang H, Han Z, Hallahan DE.

Clin Cancer Res. 2010 Oct 15;16(20):4968-77. doi: 10.1158/1078-0432.CCR-10-0969. Epub 2010 Aug 27.

36.

Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis.

Linkous AG, Yazlovitskaya EM, Hallahan DE.

J Natl Cancer Inst. 2010 Sep 22;102(18):1398-412. doi: 10.1093/jnci/djq290. Epub 2010 Aug 20.

37.

Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.

Passarella RJ, Spratt DE, van der Ende AE, Phillips JG, Wu H, Sathiyakumar V, Zhou L, Hallahan DE, Harth E, Diaz R.

Cancer Res. 2010 Jun 1;70(11):4550-9. doi: 10.1158/0008-5472.CAN-10-0339. Epub 2010 May 18.

38.

Correlation of quantified contrast-enhanced sonography with in vivo tumor response.

Hwang M, Hariri G, Lyshchik A, Hallahan DE, Fleischer AC.

J Ultrasound Med. 2010 Apr;29(4):597-607.

PMID:
20375378
39.

A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.

Thotala DK, Geng L, Dickey AK, Hallahan DE, Yazlovitskaya EM.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):557-65. doi: 10.1016/j.ijrobp.2009.09.024.

40.

Radiation induces an antitumour immune response to mouse melanoma.

Perez CA, Fu A, Onishko H, Hallahan DE, Geng L.

Int J Radiat Biol. 2009 Dec;85(12):1126-36. doi: 10.3109/09553000903242099.

PMID:
19995238
41.

Recombinant peptides as biomarkers for tumor response to molecular targeted therapy.

Passarella RJ, Zhou L, Phillips JG, Wu H, Hallahan DE, Diaz R.

Clin Cancer Res. 2009 Oct 15;15(20):6421-9. doi: 10.1158/1078-0432.CCR-09-0945. Epub 2009 Oct 13.

42.

Using in vivo biopanning for the development of radiation-guided drug delivery systems.

Jaboin JJ, Han Z, Hallahan DE.

Methods Mol Biol. 2009;542:285-300. doi: 10.1007/978-1-59745-561-9_15.

PMID:
19565908
43.

Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice.

Yang ES, Wang H, Jiang G, Nowsheen S, Fu A, Hallahan DE, Xia F.

J Clin Invest. 2009 May;119(5):1124-35.

44.

Merkel cell carcinoma.

Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass LF, Grekin RC, Hallahan DE, Kessinger A, Lee NY, Liegeois N, Lydiatt DD, Michalski J, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Olencki T, Oseroff AR, Perlis CS, Rosenberg EW, Shaha AR, Urist MM, Wang LC; NCCN Merkel Cell Carcinoma Panel.

J Natl Compr Canc Netw. 2009 Mar;7(3):322-32. No abstract available.

PMID:
19401064
45.

Cytosolic phospholipase A2: targeting cancer through the tumor vasculature.

Linkous A, Geng L, Lyshchik A, Hallahan DE, Yazlovitskaya EM.

Clin Cancer Res. 2009 Mar 1;15(5):1635-44. doi: 10.1158/1078-0432.CCR-08-1905. Epub 2009 Feb 24.

46.

A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals.

Virostko J, Xie J, Hallahan DE, Arteaga CL, Gore JC, Manning HC.

Mol Imaging Biol. 2009 May-Jun;11(3):204-12. doi: 10.1007/s11307-008-0193-9. Epub 2009 Jan 7.

47.

Determining glioma response to radiation therapy using recombinant peptides.

Diaz R, Passarella RJ, Hallahan DE.

Expert Rev Anticancer Ther. 2008 Nov;8(11):1787-96. doi: 10.1586/14737140.8.11.1787. Review.

PMID:
18983239
48.

Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.

Thotala DK, Hallahan DE, Yazlovitskaya EM.

Cancer Res. 2008 Jul 15;68(14):5859-68. doi: 10.1158/0008-5472.CAN-07-6327. Erratum in: Cancer Res. 2008 Oct 1;68(19):8189.

49.

Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium.

Yazlovitskaya EM, Linkous AG, Thotala DK, Cuneo KC, Hallahan DE.

Cell Death Differ. 2008 Oct;15(10):1641-53. doi: 10.1038/cdd.2008.93. Epub 2008 Jun 20.

50.

SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation.

Cuneo KC, Geng L, Fu A, Orton D, Hallahan DE, Chakravarthy AB.

Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):873-9. doi: 10.1016/j.ijrobp.2008.02.062.

PMID:
18514780

Supplemental Content

Loading ...
Support Center